| Literature DB >> 33542035 |
Courtney Howard1, Caren Rose2, Warren Dodd3, Katherine Kohle4, Craig Scott5, Patrick Scott6, Ashlee Cunsolo7, James Orbinski8.
Abstract
OBJECTIVES: To determine healthcare service utilisation for cardiorespiratory presentations and outpatient salbutamol dispensation associated with 2.5 months of severe, unabating wildfire smoke in Canada's high subarctic.Entities:
Keywords: accident & emergency medicine; asthma; public health
Year: 2021 PMID: 33542035 PMCID: PMC7925857 DOI: 10.1136/bmjopen-2020-037029
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
The 24-hour mean PM2.5 and PM10 from 15 June to 31 August
| Median PM2.5 (Q1, Q3)* | Maximum PM2.5
| % of days with | Median PM10
| |
| 2012 | 6.2 (5.6 to 8.9) | 65.7 | 4 (3 days) | 13.3 (9.5 to 17.9) |
| 2013 | 6.7 (4.4 to 14.5) | 67.6 | 9 (7 days) | 12.6 (8.4 to 22.0) |
| 2014 | 30.8 (16.2 to 85.0) | 320.3 | 55 (43 days) | 43.8 (26.5 to 100.7) |
| 2015 | 6.4 (4.6 to 11.5) | 99.6 | 12 (9 days) | 14.9 (10.3 to 28.8) |
*Q1—first quartile; Q3—third quartile.
Adjusted risk of cardiorespiratory emergency room visits and inpatient hospital admissions per 10 µg/m3 increase in 2-day averaged 24-hour mean PM2.5. All models adjusted for age, sex, ethnicity, day of week, humidity and temperature.
| Outcome | Emergency room visits | Inpatient hospital admissions |
| Cardiovascular basket | 0.99 (0.94 to 1.04) | 1.04 (0.98, 1.10) |
| Respiratory basket | 1.03 (1.01 to 1.05) | 1.03 (0.98 to 1.07) |
| Asthma** | ||
| ALL | 1.11 (1.07 to 1.14) | 1.11 (0.99 to 1.25) |
| Male | 1.12 (1.08 to 1.17) | 1.20 (1.01 to 1.43) |
| Female | 1.07 (1.03 to 1.12) | 1.05 (0.86 to 1.27) |
| Inuit | 1.11 (1.04 to 1.19) | 1.01 (0.78 to 1.29) |
| Dene | 1.09 (1.00 to 1.19) | NE |
| Non-Indigenous | 1.10 (1.06 to 1.15) | 1.27 (1.06 to 1.51) |
| Age <5 years | 0.99 (0.73 to 1.35) | 0.97 (0.36 to 2.61) |
| Age 5–19 years | 1.07 (1.01 to 1.14) | 1.12 (0.97 to 1.29) |
| Age 20–39 years | 1.09 (1.04 to 1.14) | 0.98 (0.71 to 1.36) |
| Age 40–59 years | 1.12 (1.07 to 1.18) | NE |
| Age ≥60 years | 1.11 (0.96 to 1.30) | NE |
| Pneumonia** | ||
| ALL | 1.06 (1.02 to 1.10) | 1.02 (0.94 to 1.11) |
| Male | 1.09 (1.04 to 1.14) | 1.04 (0.95 to 1.15) |
| Female | 1.00 (0.92 to 1.08) | 0.97 (0.82 to 1.14) |
| Inuit | 1.10 (1.06 to 1.16) | 1.09 (0.99 to 1.19) |
| Dene | NE | 0.84 (0.57 to 1.23) |
| Non-Indigenous | 0.97 (0.87 to 1.09) | 0.60 (0.26 to 1.37) |
| Age <5 years | 1.13 (1.06 to 1.20) | 1.12 (1.01 to 1.25) |
| Age 5–19 years | 1.09 (0.99 to 1.19) | 0.98 (0.79 to 1.22) |
| Age 20–39 years | 0.95 (0.78 to 1.14) | NE |
| Age 40–59 years | 0.96 (0.84 to 1.10) | 1.10 (0.92 to 1.32) |
| Age ≥60 years | 1.06 (0.99 to 1.14) | 0.80 (0.57 to 1.13) |
| Chronic obstructive pulmonary disease | ||
| ALL | 0.97 (0.89 to 1.06) | 1.11 (1.02 to 1.20) |
| Male | 0.99 (0.90 to 1.09) | 1.12 (1.02 to 1.23) |
| Female | 0.89 (0.70 to 1.14) | 1.09 (0.91 to 1.31) |
| Inuit | 0.51 (0.18 to 1.44) | 1.15 (1.01 to 1.31) |
| Dene | 0.16 (0.004 to 6.33) | 1.17 (1.04 to 1.33) |
| Non-Indigenous | 1.00 (0.91 to 1.09) | 0.66 (0.34 to 1.27) |
| Age 40–59 years | 0.81 (0.56 to 1.19) | 0.95 (0.64 to 1.42) |
| Age ≥60 years | 0.99 (0.90 to 1.08) | 1.12 (1.03 to 1.22) |
*International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada (ICD-10-CA) codes: all cardiac (I00-I52); all respiratory (J00-J99); asthma (J45-J46); pneumonia (J12-J18); chronic obstructive pulmonary disease (J44).
†Chronic obstructive pulmonary disease only in age ≥40 years.
NE, not estimable.
Figure 1The 24-hour mean PM2.5 from Yellowknife Air Quality Station on 15 June–31 August 2012–2015.
Figure 2Yellowknife Health and Social Services primary care clinic visits for respiratory symptoms and diagnoses on 15 June–31 August 2012–2015.
Standardised incidence ratios for cardiorespiratory emergency room (ER) visits in extreme fire year 2014 compared with 2012–2013
| A | B | C | D | |
| Mean observed ER visits | Number ER visits 2014 (Observed) | Standardised incidence ratio=A/B | Number ER visits 2015 | |
| Cardiovascular basket | (51+48)/2=49.5 | 62 | 1.25 (0.97, 1.60) | 63 |
| Respiratory basket | (251+239)/2=245 | 265 | 1.08 (0.95, 1.22) | 223 |
| Asthma | ||||
| ALL | (26+32)/2=29 | 59 | 2.03 (1.56, 2.61) | 21 |
| Male | (13+16)/2=14.5 | 22 | 1.52 (0.98, 2.26) | 6 |
| Female | (13+16)/2=14.5 | 37 | 2.55 (1.82, 3.48) | 15 |
| Age <5 | (1+3)/2=2 | 4 | 2.00 (0.64, 4.82) | 2 |
| Age 5–19 | (9+11)/2=10 | 13 | 1.30 (0.72, 2.17) | 7 |
| Age 20–39 | (11+12)/2=11.5 | 20 | 1.74 (1.09, 2.64) | 8 |
| Age 40–59 | (5+5)/2=5 | 19 | 3.80 (2.36, 5.82) | 4 |
| Age ≥60 | (0+1)/2=0·5 | 3 | 6.00 (1.53, 16.33) | 0 |
| Inuit | (8+8)/2=8 | 16 | 2.00 (1.18, 3.18) | 5 |
| Non-Indigenous | (13+16)/2=14.5 | 27 | 1.86 (1.25, 2.67) | 7 |
| Dene | (2+1)/2=1.5 | 5 | 3.33 (1.22, 7.39) | 2 |
| Pneumonia | ||||
| ALL | (39+40)/2=39.5 | 62 | 1.57 (1.21, 2.00) | 43 |
| Male | (19+19)/2=19 | 38 | 2.00 (1.44, 2.72) | 25 |
| Female | (20+21)/2=20.5 | 24 | 1.17 (0.77, 1.72) | 18 |
| Age <5 | (6+4)/2=4.5 | 16 | 3.56 (2.11, 5.65) | 13 |
| Age 5–19 | (2+6)/2=4 | 13 | 3.25 (1.81, 5.42) | 4 |
| Age 20–39 | (2+4)/2=3 | 9 | 3.00 (1.46, 5.51) | 11 |
| Age 40–59 | (15+10)/2=12.5 | 9 | 0.72 (0.35, 1.32) | 4 |
| Age ≥60 | (14+17)/2=15.5 | 15 | 0.97 (0.56, 1.56) | 11 |
| Inuit | (14+12)/2=13 | 29 | 2.23 (1.52, 3.16) | 15 |
| Non-Indigenous | (12+12)/2=12 | 15 | 1.25 (0.73, 2.02) | 9 |
| Dene | (3+8)/2=5.5 | 3 | 0.55 (0.14, 1.48) | 8 |
| Chronic obstructive pulmonary disease* | ||||
| All | (20+18)/2=19 | 11 | 0.58 (0.29,1.04) | 16 |
*Subgroup analyses were not performed for chronic obstructive pulmonary disease because case numbers were too small.